Pre- and early postoperative GFAP serum levels in glioma and brain metastases

Peter Baumgarten*, Johanna Quick-Weller, Florian Gessler, Marlies Wagner, Julia Tichy, Marie Therese Forster, Christian Foerch, Volker Seifert, Michel Mittelbronn, Christian Senft

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)

Abstract

Subject: To date there is no established tumor marker for the clinical follow-up of glioblastoma, WHO grade IV, (GBM) which constitutes the most frequent and malignant primary brain tumor. However, since there is promising data that the serum glial fibrillary acidic protein (sGFAP) may serve as a biomarker for glial brain tumors, this prospective study aimed at evaluating the diagnostic relevance of perioperative changes in sGFAP levels for the assessment of residual glial tumor tissue in patients undergoing surgery of intracerebral tumors. Methods: Serum GFAP was measured using an electrochemiluminometric immunoassay (ElecsysR GFAP prototype test, Roche Diagnostics, Penzberg/Germany) in 32 prospectively recruited patients between September 2009 and August 2010. Twenty-five were diagnosed with glioma and seven with brain metastases (BM). We assessed sGFAP levels prior to and at different time points during the early postoperative phase until patient discharge. Results: There were only significant differences in the pre-operative sGFAP levels of patients with gliomas compared to BM (0.18 vs. 0.08 µg/l; p = 0.0198, Welch’s t-Test). Even though there was an increase of sGFAP after surgery, there were no significant differences between glioma and BM patients at any other time point. Peak sGFAP levels where reached on postoperative day 1 followed by a slight decrease, but not reaching pre-operative levels until postop day 7. There was no significant correlation between postoperative glioma tumor volume and sGFAP levels in univariate analyses. Conclusion: According to our data sGFAP does not appear to be suitable to detect residual glioma tissue in the acute postoperative phase.

Original languageEnglish
Pages (from-to)541-546
Number of pages6
JournalJournal of Neuro-Oncology
Volume139
Issue number3
DOIs
Publication statusPublished - 1 Sep 2018

Keywords

  • Biomarker
  • Brain metastasis
  • GFAP
  • Glioblastoma
  • Resection

Fingerprint

Dive into the research topics of 'Pre- and early postoperative GFAP serum levels in glioma and brain metastases'. Together they form a unique fingerprint.

Cite this